| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.6 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |